The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Primary and Secondary Prevention of Cardiovascular Disease
Open accessAbstract
Background This guideline focuses on long-term administration of antithrombotic drugs designed for primary and secondary prevention of cardiovascular disease, including two new antiplatelet therapies. Methods The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines in this supplement. Results We present 23 recommendations for pertinent clinical questions. For primary prevention of cardiovascular disease, we suggest low-dose aspirin (75-100 mg/d) in patients aged > 50 years over no aspirin therapy (Grade 2B). For patients with established coronary artery disease, defined as patients 1-year post-acute coronary syndrome, with prior revascularization, coronary stenoses > 50% by coronary angiogram, and/or evidence for cardiac ischemia on diagnostic testing, we recommend long-term low-dose aspirin or clopidogrel (75 mg/d) (Grade 1A). For patients with acute coronary syndromes who undergo percutaneous coronary intervention (PCI) with stent placement, we recommend for the first year dual antiplatelet therapy with low-dose aspirin in combination with ticagrelor 90 mg bid, clopidogrel 75 mg/d, or prasugrel 10 mg/d over single antiplatelet therapy (Grade 1B). For patients undergoing elective PCI with stent placement, we recommend aspirin (75-325 mg/d) and clopidogrel for a minimum duration of 1 month (bare-metal stents) or 3 to 6 months (drug-eluting stents) (Grade 1A). We suggest continuing low-dose aspirin plus clopidogrel for 12 months for all stents (Grade 2C). Thereafter, we recommend single antiplatelet therapy over continuation of dual antiplatelet therapy (Grade 1B). Conclusions Recommendations continue to favor single antiplatelet therapy for patients with established coronary artery disease. For patients with acute coronary syndromes or undergoing elective PCI with stent placement, dual antiplatelet therapy for up to 1 year is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence supports use of either ticagrelor or clopidogrel if no percutaneous coronary intervention was performed and clopidogrel, ticagrelor, or prasugrel if a percutaneous coronary intervention was performed (199).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [199]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Evidence supports use of either ticagrelor or clopidogrel if no percutaneous coronary intervention was performed and clopidogrel, ticagrelor, or prasugrel if a percutaneous coronary intervention was performed (187).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [187]
In the citing paper
“Evidence supports use of either ticagrelor or clopidogrel if no percutaneous coronary intervention was performed and clopidogrel, ticagrelor , or prasugrel if a percutaneous coronary intervention was performed (162).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [162]
In the citing paper
“Co-prescription of OAC with antiplatelet therapy, in particular triple therapy, 1501 increases the absolute risk of major haemorrhage.445,517,518”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [517]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm
Lip, G. Y. H., Wrigley, B., & Pisters, R. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003333 · Cited by 32
RetractedPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Self-citationHansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Flagged first, then by citations
1 of the 118 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Wilson, 1998, Prediction of coronary artery disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837 · DOI · Paper page
Cited by
Sorted by citations
Items 401–475 of 475
Management of the Urological Patient Taking Anticoagulant or Antiplatelet Medication
Kagalwala, D. Z., Ajvadi, F., & Fischer, G. W. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7363-3_13
Significant Changes to Antithrombotic Therapy and Prevention of Thrombosis Guidelines
Zarowitz, B. J. M. (2012) · Geriatric Nursing · doi:10.1016/j.gerinurse.2012.06.002
Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants After Stent Implantation
Kunadian, V., Dunford, J. R., Swarbrick, D. J., Halaby, R. N., Ajari, O. W., Cochet, M., Kostka, K., Larkin, E., Gonzalez, G. R., Govindavarjhulla, A., et al. (2013) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2013.05.007
Turpie, A. G. G. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.938055
Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation
Madhavan, M. V., & Kirtane, A. J. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0598-4
Franco, A. C. D., & Oldridge, N. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.861743
Villalobos, C. J., Carvajal, C. A., Mor, J. D., Rendón, I. D., Caycedo-González, L. A., Lopez, V. J., Martínez, S., & Parra, J. A. (2013) · Revista Colombiana de Cardiología · doi:10.1016/s0120-5633(13)70029-9
Prophylactic aspirin and public health
Elwood, P. C., & Longley, M. J. (2012) · Journal of Public Health · doi:10.1093/pubmed/fds051
Management of Warfarin Therapy
Krueger, C. (2012)
Halperin, J. L., Lip, G. Y. H., Hughes, M., Spencer, F. A., Manning, W. J., Eckman, H., Fang, M. C., Hylek, E. M., Schulman, S., Singer, D. E., et al. (2012)
Self-citationBalancing Act: How to Individualize Anti-ischemic Therapy in the New Era of
Prevention, A. S. (2012)
Writers, A. M. (2015) · Drugs & Therapy Perspectives · doi:10.1007/s40267-015-0261-6
Acetylsalicylic acid for the prevention of primary myocardial infarction and ischemic stroke
Samorodskaya, I. V., Валентиновна, Б. Е., & Boytsov, S. A. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587991-96
Medical and Invasive Management of Coronary Artery Disease in Patients on Anticoagulants
Berg, R., & Shafi, N. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20415-4_12
Cardiovascular Disease in Pregnancy
Hill, A. J., & Pacheco, L. D. (2012) · NeoReviews · doi:10.1542/neo.13-11-e651
Solaymani–Dodaran, M., Card, T. R., & West, J. (2013)
Grundzüge Diagnostik und Therapie der PAVK bei Diabetikern
Lawall, H. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0783-6
Old complication, new presentation: a case of the spleen taking the bullet
Isted, A., Fiorini, F., & Mota, P. C. (2015) · BMJ Case Reports · doi:10.1136/bcr-2015-210299
Using antiplatelet agents in clinical practice
Russian Federation Moscow (2014) · CyberLeninK (CyberLeninka)
Anti-Platelet Therapy in Acute Coronary Syndromes: Updates in Therapy After Stent Implantation
McKenzie, R., Park, A., & Tsu, L. V. (2012) · Chapman University Digital Commons (Chapman University)
Management of Chronically Anticoagulated Patients
Levy, J. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-28308-1_33
Role of Antiplatelet Therapy in Neurosurgery: Efficacy and Safety Profiles
Bowen, N., & Mousa, S. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-27327-3_6
CHOICE OF ANTITHROMBOTIC THERAPY FOLLOWING ACUTE CORONARY SYNDROME
Eniseeva, E. S. (2013) · CyberLeninK (CyberLeninka)
Nonarteriosclerotic Arterial Occlusive Disease
Moll, S. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00022-1
Anticoagulation in Cardiovascular Diseases
Memon, S. B., Bakhos, L., & Syed, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27327-3_15
Er:yag Laser assisted Endodontic Surgery in the Era of New Antithrombotic Treatments
Sahar-Helft, S., Stabholtz, A., Polak, D., & Findler, M. (2016) · Dentistry · doi:10.4172/2161-1122.1000395
Thrombotics and Antithrombotics
Slattery, D. E., & Pollack, C. V. (2012)
High-on-Aspirin Residual Platelet Reactivity Evaluated Using the Multiplate ® Point-of-Care Device
Mărginean, A., Moldovan, V. G., & Mărginean, M. (2016) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2015-0124
Chapter 15. Ischemic Heart Disease and Acute Coronary Syndrome
(2015) · The American Pharmacists Association eBooks · doi:10.21019/9781582122175.ch15
Utility of the new gold classification for COPD in alpha one antitrypsin deficiency
Pillai, A. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
Minushkina, L. O. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-4-89-93
Update of Antiplatelet Therapy in Patients Without Known Cardiovascular Disease
Tomasevic, M. V., Aleksandric, S. B., & Stojkovic, S. M. (2017) · Serbian Journal of Experimental and Clinical Research · doi:10.1515/sjecr-2017-0013
Cardiovascular Drugs and Hemostasis
Farsad, B. F., & Salehi, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-51149-0.00034-1
Singh‐Franco, D., Hale, G. M., & Jacobs, R. J. (2017) · Hospital Practice · doi:10.1080/21548331.2018.1415621
Antiplatelet Therapy in Cardiovascular Medicine
Savji, N., & Berger, J. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00021-2
Carson, E., & Hemenway, A. N. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028018825140
Antiplatelet Therapy Considerations in Women
Esmail, K., & Angiolillo, D. J. (2019) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2017.0079
Antithrombotic Therapy for Cardiac Disease
Shatzel, J. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-19330-0_20
Davis, J. P. E., & Intagliata, N. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-24490-3_12
Gómez-Huelgas, R., Pérez‐Jiménez, F., Serrano‐Ríos, M., González‐Santos, P., Román, P., Camafort, M., Conthe, P., García‐Alegría, J., Guijarro, R., López‐Miranda, J., et al. (2014) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2014.04.001
Elshafei, M. N., Imam, Y. Z. B., Mohamed, M. F. H., Alsaud, A., Abdelmoneim, M. S., Obeidat, K., Saeid, R., Ali, M. Y., Abdallah, I. M. H., Parray, A., et al. (2020) · Medicine · doi:10.1097/md.0000000000020307
Aspirin associated with a decreased incidence of uterine cancer
Li, P., Sung, F., Yang, Y., Chen, W., Wang, J., Lin, S., & Ding, D. (2020) · Medicine · doi:10.1097/md.0000000000021446
Secondary Stroke Prevention and Management for the Neuro-Ophthalmologist
Rahman, L. A., Wabnitz, A., & Turan, T. N. (2020) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001133
Modern principles of antiplatelet antithrombotic therapy
Popova, L. V. (2017) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-7-586-593
ASS in der Primär- und Sekundärprävention kardiovaskulärer Erkrankungen
Hach, A., Sauter, M., & Langer, H. F. (2020) · Kardiologie up2date · doi:10.1055/a-0917-8604
Platelet physiology and pharmacology—relevant considerations for patient care
Lee, C. H., & Angiolillo, D. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820536-5.00005-7
Ramos, J., & Yu, E. Y. (2017) · The Journal of Urology · doi:10.1016/j.juro.2016.12.094
항응고제 치료를 받고 있는 환자의 수술 및 시술 시 관리
주진 (2014)
Matsuzaki, S., Miller, H., Takiuchi, T., Klar, M., & Matsuo, K. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1973427 · Cited by 1
Almalki, S., Alhossan, A., Alrumayyan, B., Alanazi, K., Gamea, S. B., Alesikri, M., Ahmad, A., & Alrabiah, Z. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.10.010
Diabetes Mellitus: Alterations in Vessel Wall Properties
Cardoso, C. R. L., & Salles, G. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-14556-3_16
Current State of the Art for Prophylactic Treatment of Thromboembolic Events After TKA
Jenny, J. (2021) · Springer eBooks · doi:10.1007/978-3-662-63113-3_51
Paneni, F., & Cosentino, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17762-5_11
Management of Chronically Anticoagulated Patients
Levy, J. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-53606-0_39
Azamakhlaghi, A., Alimohammadzadeh, K., Hosseini, S. M., Maher, A., & Jafari, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1959362/v1
Secondary Diseases of the Kidney
Natale, P., Wong, M. G., Strippoli, G. F., Tunnicliffe, D. J., Cooper, T. E., & Pollock, C. A. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch24
Pharmacokinetics of a new antiplatelet agent, an indolinone derivative in the experiment
Быков, В. В., Быкова, А. В., Андреевич, Л. К., Венгеровский, А. И., & Удут, В. В. (2022) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2022-6-4-77-86
Research Progress of Left Ventricular Thrombus Formation
邱, 倩. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141305
Singh, M., Momah, D. U., Palaniappan, D., Nadig, V., & Mah, J. (2024) · A&A Practice · doi:10.1213/xaa.0000000000001741
Sapalo, A. T. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007496
Albaeni, A., Li, S., Shan, Y., Thakker, R. A., Gaalema, D. E., Saxena, R., Kuo, Y., Jneid, H. M., & Goodwin, J. H. (2024) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.11.006
Detection and Treatment of Chronic Complications
Soe, K. K., & Gunasekaran, U. (2020) · American Diabetes Association eBooks · doi:10.2337/9781580406314.ch05
Alimi, H., & Tajik, A. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x363285250519064030
Monday’s medical myth: take an aspirin a day after you turn 50
Tam, C. W. M. (2012) · doi:10.64628/aa.wvdtuv4ck
Cardiovascular Disease and Risk Management
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch17
Medical Optimization of Patients Prior to Surgery
Marhefka, G. D., & Merli, G. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7928-4_4
Pannunzio, A., Palumbo, I., Donadini, M. P., Santagata, D., Ageno, W., Dragoni, F., Chistolini, A., Becattini, C., Satula, K., Menichelli, D., et al. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04235-4
Mootz, N., Dugaesescu, A., Rehman, H., Samayam, N., Andes, B., Hansen, T., & Lin, C.-J. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001215
Kyriakoulis, I., Csécs, I., Ahmed, A. I., Wright, C. X., Shanbhag, A. D., Lemley, M. H., Slomka, P. J., Sinusas, A. J., Miller, E. J., Kokkinidis, D. G., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102732
Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence
Lipps, K. M., Elbenawi, H., Heller, S., McBane, R. D., Wysokiński, W. E., Casanegra, A. I., Henkin, S., Rooke, T. W., Wennberg, P. W., Liedl, D., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102873
Clinical Epidemiology and Evidence-Based Health Care
Germini, F., Marcucci, M., Bognanni, A., & Schünemann, H. J. (2025) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_30-1
Bleeding and haemostasis disorders
Mannucci, P. M., & Lettino, M. (2021) · doi:10.1093/med/9780198849346.003.0069_update_001
Metadata
- Authors
- Vandvik, P. O., Lincoff, A. M., Gore, J. M., Gutterman, D. D., Sonnenberg, F. A., Alonso-Coello, P., Akl, E. A., Lansberg, M. G., Guyatt, G. H., & Spencer, F. A.
- Affiliations
- Innlandet Hospital Trust (NO)
- Cleveland Clinic (US)
- University of Massachusetts Chan Medical School (US)
- Medical College of Wisconsin (US)
- University of Medicine and Dentistry of New Jersey (US)
- University at Buffalo, State University of New York (US)
- Stanford Medicine (US)
- McMaster University (CA)
- Corresponding author
- Spencer, Frederick A.
- ORCID
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 141
- Issue
- 2
- Pages
- e637S-e668S
- ISSN
- 0012-3692 (ISSN-L)
- PMC
- PMC3278064
- OpenAlex
- W2116051185
- Cited by
- 476
- References
- 118
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 11 · 2023: 6 · 2022: 23 · 2021: 19 · 2020: 32 · 2019: 36 · 2018: 29 · 2017: 44 · 2016: 46 · 2015: 59 · 2014: 58 · 2013: 64 · 2012: 37
- FWCI
- 44.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- CHEST Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Sanofi
- National Heart, Lung, and Blood Institute (R13HL104758)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- cardiovascular disease prevention, antithrombotic therapy, antiplatelet therapy, low-dose aspirin, clopidogrel, ticagrelor, prasugrel, dual antiplatelet therapy, single antiplatelet therapy, acute coronary syndrome, percutaneous coronary intervention, coronary artery disease, drug-eluting stents, bare-metal stents, long-term aspirin therapy
- MeSH terms
- Aged, Cardiovascular Diseases, Combined Modality Therapy, Coronary Disease, Dose-Response Relationship, Drug, Drug Therapy, Combination, Fibrinolytic Agents, Humans, Long-Term Care, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Societies, Medical, Thrombosis, Stents, Angioplasty, Balloon, Coronary, Myocardial Ischemia, Evidence-Based Medicine, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
